Altre lingue Invion Limited

Azioni

IVX

AU000000IVX4

Tempo differito Australian S.E. Altri mercati azionari 04:20:32 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,006 ^AUD	0,00%		+20,00%	+20,00%

05/03	Il farmaco antitumorale di Invion registra risultati positivi nella sperimentazione preclinica	MT
27/02	Invion Limited riporta i risultati degli utili per il semestre terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	05/03
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%	23/02
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production	21/11
Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea	26/09/23
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Invion Launches New Interactive Investor Hub	11/04/23
Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.	06/04/23
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23
Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong	08/02/23
Invion Limited Announces Vitro Test Results on Photosoft	26/10/22
Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus	24/10/22
Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer	15/09/22
Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro	15/09/22
Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays	08/09/22
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022	18/08/22
Invion : Activities Report and Appendix 4C	21/07/22
Invion : Notification regarding unquoted securities - IVX	20/06/22
Invion's Cancer Treatment Patent Application Published	09/06/22
Invion Limited Announces International Patent to Extend IP Protection for Photosoft	08/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Invion Limited

Azioni

IVX

AU000000IVX4

Altre lingue

Filtri